| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |